The Condensed Consolidated Statements of Cash Flows explain the changes in the total of cash, cash equivalents and restricted

cash. The following table presents a reconciliation of cash, cash equivalents and restricted cash, such as cash amounts deposited in

restricted cash accounts in connection with the Company’s credit cards, reported for each period within the Condensed Consolidated Balance

Sheets and the Condensed Consolidated Statements of Cash Flows that sum to the total of such amounts.


	June 30, 2026	December 31, 2025	June 30, 2025
	(In thousands)
Cash and cash equivalents	$61,438	$48,076	$57,050
Restricted cash, non-current (included in other assets, non-current)	—	—	131
Total cash, cash equivalents and restricted cash	$61,438	$48,076	$57,181

Inventory amounts are stated at the lower of cost or net realizable value, using the first-in, first-out method.


	June 30, 2026	December 31, 2025
	(In thousands)
Raw materials	$10,144	$8,289
Work in process	9,095	6,270
Finished goods	21,831	10,768
Inventories, gross	41,070	25,327
Valuation adjustments for excess and obsolete inventory	(2,828)	(1,067)
Inventories, net	$38,242	$24,260

Goodwill is tested for impairment annually in the third quarter of the Company’s fiscal year or more frequently if indicators of potential

impairment exist. The Company monitors the industries in which it operates and reviews its business performance for indicators of potential

impairment. The recoverability of goodwill is measured at the reporting unit level, which represents the operating segment.

segment due to a fundamental change in the outlook of the business. The Company considered the wind down to be an indicator of

impairment and performed a quantitative impairment test using the discounted cash flow approach and market approach. Based on the

results of the analysis, the Company determined that the carrying value of the reporting unit exceeded its fair value and recorded an

impairment charge of $1.7 million during the six months ended June 30, 2026. No impairment charges were recorded during the three


	June 30, 2026	December 31, 2025
	(In thousands)
Accrued expenses and other liabilities, current
Payroll, benefits, incentives and commissions payable	$5,579	$6,683
Warranty reserve	175	205
Restructuring accrual	1,098	—
Income taxes payable	10	2,401
Other accrued expenses and other liabilities	2,928	2,381
Total accrued expenses and other liabilities	9,790	11,670

Other liabilities, non-current	1,120	1,070
Total accrued expenses, and current and non-current other liabilities	$10,910	$12,740

the G&A function, in order to lower the Company’s operating cost structure, and to position the Company for profitable growth. The Company

recorded a restructuring charge of approximately $2.8 million in total, of which $0.5 million was recorded during the six months ended June

30, 2025. No restructuring charges were recorded during the three months ended June 30, 2025. The total restructuring charge recorded

relates to severance and benefits, including reemployment assistance, for 38 terminated employees, which was approximately 15% of the

Company’s workforce. The restructuring plan was complete as of December 31, 2025. All expenses associated with the Company’s

restructuring plan are included in “Restructuring charges” in the Condensed Consolidated Statements of Operations.

During the first quarter of fiscal year 2026, the Company wound down operations of the CO2 retail grocery business within its

Emerging Technologies segment due to a fundamental change in the outlook of the business. The Company recorded a restructuring charge

of approximately $2.4 million during the six months ended June 30, 2026, of which $0.9 million was recorded during the three months ended

June 30, 2026. The restructuring charge recorded relates to severance and benefits, including reemployment assistance, for 23 terminated

employees. In addition, during the six months ended June 30, 2026, the Company incurred other related charges associated with the wind

down of the CO2 retail grocery business, including excess and obsolescence reserves taken on CO2 inventory of approximately $1.6 million

and impairment of goodwill of approximately $1.7 million, which are included in “Restructuring - inventory reserve” and “Impairment of

goodwill” in the Condensed Consolidated Statements of Operations, respectively. The Company did not incur any excess and obsolescence

reserves or impairments of goodwill during the three months ended June 30, 2026. Refer to section Goodwill within this footnote for additional

information. The restructuring plan was substantially complete by the end of the second quarter of fiscal year 2026 and the Company does

and other liabilities on the Condensed Consolidated Balance Sheets, during the six months ended June 30, 2026:


	Severance and Benefits
	(In thousands)
Balance, as of December 31, 2024	$2,476
Restructuring provision, net of adjustments	313
Cash paid	(2,789)
Balance, as of December 31, 2025	$—
Restructuring provision	2,391
Cash paid	(1,236)
Balance, as of June 30, 2026	$1,155